4-Hydroxy-1H-indole-3-carbaldehyde

Catalog No.: 
ACFRDI135
CAS No.: 
81779-27-3
Molecular Formula: 
C9H7NO2
Molecular Weight: 
161.16
4-Hydroxy-1H-indole-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$58.00In stockInquiry
5g95%$175.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Hydroxy-1H-indole-3-carbaldehyde
IUPAC Name4-hydroxy-1H-indole-3-carbaldehyde
MDL No.MFCD05864721
Molecular FormulaC9H7NO2
Molecular Weight161.16
SMILESOC1=C2C(=CC=C1)[NH]C=C2C=O
InChI KeyQLBZIZLLMNWTHG-UHFFFAOYSA-N
SynonymZinc02563745;3-Formyl-4-hydroxy-1H-indole;4-Hydroxyindole-3-carboxaldehyde;4-Hydroxyindole-3-carboxaldehyde 98%;4-HYDROXY-1H-INDOLE-3-CARBALDEHYDE;4-HYDROXY-1H-INDOLE-3-CARBOXALDEHYDE;1H-Indole-3-carboxaldehyde,4-hydroxy-;4-hydroxy-1H-indol-3-carbaldehyde
CAS No.81779-27-3
PubChem CID9815282

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFRDI135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDSZM093 route compound structure diagram
    ACDSZM0932380-94-1In Stock
  4. Then
  5. ACFRDI135 route product structure diagram
    ACFRDI13581779-27-3In Stock
Inquiry

2. ACFRDI135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEAJQ857 route compound structure diagram
    ACEAJQ85790734-97-7In Stock
  2. Then
  3. ACFRDI135 route product structure diagram
    ACFRDI13581779-27-3In Stock
Inquiry

3. ACFRDI135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDRQA471 route compound structure diagram
    ACDRQA4717042-71-9In Stock
  2. Then
  3. ACFRDI135 route product structure diagram
    ACFRDI13581779-27-3In Stock
Inquiry

Comments (0)